X4 Pharmaceuticals (XFOR) Receivables - Other (2018 - 2025)
Historic Receivables - Other for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $715000.0.
- X4 Pharmaceuticals' Receivables - Other fell 3336.44% to $715000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $715000.0, marking a year-over-year decrease of 3336.44%. This contributed to the annual value of $640000.0 for FY2024, which is 1387.9% up from last year.
- Per X4 Pharmaceuticals' latest filing, its Receivables - Other stood at $715000.0 for Q3 2025, which was down 3336.44% from $720000.0 recorded in Q2 2025.
- X4 Pharmaceuticals' Receivables - Other's 5-year high stood at $1.2 million during Q4 2022, with a 5-year trough of $393000.0 in Q3 2023.
- For the 5-year period, X4 Pharmaceuticals' Receivables - Other averaged around $778315.8, with its median value being $747000.0 (2021).
- In the last 5 years, X4 Pharmaceuticals' Receivables - Other crashed by 5676.57% in 2023 and then surged by 17302.8% in 2024.
- Quarter analysis of 5 years shows X4 Pharmaceuticals' Receivables - Other stood at $747000.0 in 2021, then skyrocketed by 54.22% to $1.2 million in 2022, then tumbled by 51.22% to $562000.0 in 2023, then grew by 13.88% to $640000.0 in 2024, then increased by 11.72% to $715000.0 in 2025.
- Its Receivables - Other stands at $715000.0 for Q3 2025, versus $720000.0 for Q2 2025 and $665000.0 for Q1 2025.